COYACoya Therapeutics Inc. Common Stock
4.870USD-2.01%Mkt Cap: 114.24M $P/E: —3d ago
Coya Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of proprietary therapies to enhance the function of regulatory T cells (Tregs). Its candidate product pipeline is based on thera…